{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T17:50:36Z","timestamp":1769017836553,"version":"3.49.0"},"reference-count":19,"publisher":"Baishideng Publishing Group Inc.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Gastrointest Oncol"],"abstract":"<jats:p>BACKGROUND<\/jats:p>\n          <jats:p>The advanced first-line regimen for advanced gastric cancer is based on a combination of fluoropyrimidine and platinum and\/or paclitaxel (PTX), forming a two- or three-drug regimen. Compared to conventional PTX, nanoparticle albumin-bound PTX (Nab-PTX) has better therapeutic effects and fewer adverse effects reported in studies. Nab-PTX is a great option for patients presenting with advanced gastric cancer. Herein, we highlight an adverse event (hemorrhagic cystitis) of Nab-PTX in advanced gastric cancer.<\/jats:p>\n          <jats:p>CASE SUMMARY<\/jats:p>\n          <jats:p>A 55-year-old male was diagnosed with lymph node metastasis after a laparoscopic-assisted radical gastrectomy for gastric cancer that was treated by Nab-PTX and S-1 (AS). On the 15th day after treatment with AS, he was diagnosed with hemorrhagic cystitis.<\/jats:p>\n          <jats:p>CONCLUSION<\/jats:p>\n          <jats:p>Physicians should be aware that hemorrhagic cystitis is a potential adverse event associated with Nab-PTX treatment.<\/jats:p>","DOI":"10.4251\/wjgo.v16.i3.1084","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T02:02:20Z","timestamp":1710208940000},"page":"1084-1090","source":"Crossref","is-referenced-by-count":2,"title":["Hemorrhagic cystitis in gastric cancer after nanoparticle albumin-bound paclitaxel: A case report"],"prefix":"10.4251","volume":"16","author":[{"given":"Xin-Jie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","published-online":{"date-parts":[[2024,3,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2020.06.03"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12193"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-019-0164-y"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172307"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2013.05.041"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000000501"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(16)30219-9"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/17588359221118020"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2016.08.003"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1159\/000496331"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.Cd003231"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-006-0078-0"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s13691-016-0255-9"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4137\/cmo.s4477"},{"key":"B16","unstructured":"Langer CJ, Leighton J, McAleer C, Comis R, O'Dwyer P, Ozols R. Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer. Semin Oncol 1995; 22: 64-69"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4103\/ijp.ijp_640_22"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1089\/end.2014.0683"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122096"}],"container-title":["World Journal of Gastrointestinal Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/1948-5204\/full\/v16\/i3\/1084.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/1948-5204\/full\/v16\/i3\/1084.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T02:05:27Z","timestamp":1710209127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/1948-5204\/full\/v16\/i3\/1084.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,15]]},"references-count":19,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.4251\/wjgo.v16.i3.1084","relation":{},"ISSN":["1948-5204"],"issn-type":[{"value":"1948-5204","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,15]]}}}